Rassf1a-knockout mice exhibit clinicopathological abnormalities of IBD (increases in intestinal permeability, production of cytokines and chemokines, NF-κB overexpression, and epithelial cell damage), affirming the protective function of RASSFs [192]. Here, RASSF1 is linked to inflammatory bowel disease.